BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1899118)

  • 1. Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure.
    Bauer JA; Fung HL
    J Pharmacol Exp Ther; 1991 Jan; 256(1):249-54. PubMed ID: 1899118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular and hemodynamic differences between organic nitrates and nitrites.
    Bauer JA; Nolan T; Fung HL
    J Pharmacol Exp Ther; 1997 Jan; 280(1):326-31. PubMed ID: 8996213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravenous nitroglycerin on hemodynamics in infants and children with congestive heart failure.
    Zeng H; Sun L; Li W; Du J
    Chin Med J (Engl); 2000 Apr; 113(4):328-31. PubMed ID: 11775229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrate tolerance: effect of thiol supplementation during prolonged nitroglycerin infusion in an in vivo rat model.
    Boesgaard S; Petersen JS; Aldershvile J; Poulsen HE; Flachs H
    J Pharmacol Exp Ther; 1991 Sep; 258(3):851-6. PubMed ID: 1909757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro vasorelaxant and in vivo cardiovascular effects of S-nitrosothiols: comparison to and cross tolerance with standard nitrovasodilators.
    Smith MP; Humphrey SJ; Kerr SW; Mathews WR
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):323-35. PubMed ID: 7934311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo depletion of free thiols does not account for nitroglycerin-induced tolerance: a thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance.
    Haj-Yehia AI; Benet LZ
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1296-305. PubMed ID: 8819515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrosothiol and nitrate tolerance.
    Fung HL; Poliszczuk R
    Z Kardiol; 1986; 75 Suppl 3():25-7. PubMed ID: 3099484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
    Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S
    Arzneimittelforschung; 1998 Feb; 48(2):125-32. PubMed ID: 9541721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamic response to high-dose nitroglycerin infusion in patients with severe heart failure after pretreatment and clinical stabilization].
    Faggiano P; Rusconi C
    G Ital Cardiol; 1991 Nov; 21(11):1195-202. PubMed ID: 1809623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous versus arterial actions of diethylamine/nitric oxide (DEA/NO) complex and S-nitroso-N-acetylpenicillamine (SNAP) in vivo.
    Ng SS; Pang CC
    Br J Pharmacol; 1998 Nov; 125(6):1247-51. PubMed ID: 9863653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of apparent elimination half-life on nitroglycerin-induced hemodynamic rebound in experimental heart failure.
    Bauer JA; Fung HL
    Pharm Res; 1993 Sep; 10(9):1341-5. PubMed ID: 8234174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic models of nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
    Bauer JA; Fung HL
    Pharm Res; 1994 Jun; 11(6):816-23. PubMed ID: 7937519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nitrate tolerance and its management by N-acetylcysteine (studies of patients with severe chronic heart failure)].
    Bodemann T; Langescheid C; Hochrein H
    Z Kardiol; 1989 May; 78(5):328-34. PubMed ID: 2499991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrate tolerance: comparison of nicorandil, isosorbide dinitrate, and nitroglycerin in anesthetized dogs.
    Sakai K; Kuromaru O
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S17-24. PubMed ID: 2447420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits.
    Shaffer JE; Han BJ; Chern WH; Lee FW
    J Pharmacol Exp Ther; 1992 Jan; 260(1):286-93. PubMed ID: 1731043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.
    Kowaluk EA; Fung HL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1256-64. PubMed ID: 2175799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of intravenous nitroglycerin: importance of the delivery system.
    Mutch WA; Culligan JD; Cote DD; Thomson IR
    Anesth Analg; 1982 Nov; 61(11):927-32. PubMed ID: 6814298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiol-mediated catalysis of nitroglycerin degradation by serum proteins. Increase in metabolism was not accompanied by S-nitrosothiol production.
    Chong S; Fung HL
    Drug Metab Dispos; 1990; 18(1):61-7. PubMed ID: 1970779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The advantageous effects of a prolonged intravenous load with a nitroglycerin solution on the lesser circulation in patients with chronic heart failure].
    Kazeĭ DV; Mareev VIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(2):27-34. PubMed ID: 3148308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nitroglycerin on left ventricular diastolic properties in man.
    Amende I; Simon R; Hood WP; Lichtlen PR
    Z Kardiol; 1983; 72 Suppl 3():62-5. PubMed ID: 6421016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.